When we stratified the participants into subgroups, Caspase-1 exhibited comparable expression levels in NAFLD, NASH, and HCV-nMet, while it was significantly more abundant in subjects with HCV-infection associated with the metabolic disorder (HCV-Met) (Figure 2d). The gene discussed is CASP1; the disease is metabolic dysfunction-associated steatotic liver disease.